Sue Hohenleitner,

Vice President of Finance, Johnson & Johnson Innovation

Sue provides strategic finance planning and management leadership and oversight to Johnson & Johnson Innovation as well as Business Development at the Janssen Pharmaceutical Companies of Johnson & Johnson.

Sue is a strong financial business partner and Credo-based leader who, throughout her tenure at Johnson & Johnson, has provided strategic financial counsel across the Pharmaceutical, Medical Device and Consumer Health sectors and Corporate Investor Relations. She also served as the J&J lead on an extensive 18-month journey with the Coalition for Inclusive Capitalism, exploring new ways to measure a company’s long-term value in cooperation with other multinational corporations, asset managers and asset owners.

Before joining Johnson & Johnson, Sue was an auditor for Arthur Andersen, LLP in Philadelphia, PA.  Sue received her MBA from Villanova University and a Bachelor of Science degree in Accounting from La Salle University, where she currently serves as Treasurer on the Alumni Board.  She is CPA licensed in the Commonwealth of Pennsylvania and a Certified Management Accountant.

Sue lives near Philadelphia with her husband and 3 teenagers and is an active member of the community where she lives.  Her favorite non-work activities include spending time with her husband and children and some early morning runs to clear her mind for the challenges of each day.

Sue Hohenleitner
Sue Hohenleitner